• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:谢燕,邓仕任,曹艺凡,李汉月,邹烨,夏林波.基于指纹图谱、化学计量学及网络药理学的小陷胸汤干预糖尿病前期的质量标志物分析[J].药学研究,2025,44(12):1153-1160[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2131次   下载 774次 本文二维码信息
码上扫一扫!
基于指纹图谱、化学计量学及网络药理学的小陷胸汤干预糖尿病前期的质量标志物分析
谢燕,邓仕任,曹艺凡,李汉月,邹烨,夏林波
字体:加大+|默认|缩小-
(辽宁中医药大学药学院,辽宁 大连 116600)
摘要:
目的 通过指纹图谱和化学计量学、网络药理学筛选小陷胸汤质量标志物(Q-Marker)。方法 基于指纹图谱结合化学计量学筛选小陷胸汤差异性成分,进一步采用网络药理学技术筛选与小陷胸汤治疗糖尿病前期相关联的Q-Marker,并通过超高效液相色谱(UPLC)对Q-Marker进行含量测定。结果 建立了15批小陷胸汤样品的指纹图谱,共标定24个共有峰。化学计量学分析将15批小陷胸汤样品聚为4个组别,正交偏最小二乘法-判别分析(OPLS-DA)显示变量重要性投影值(VIP值)大于1的差异峰有13个,通过对照品指认了其中9个。对上述9种差异标志物进行网络药理学分析,最终筛选出5种核心活性成分(香草酸、芦丁、木犀草苷、药根碱、小檗碱),可作用于ESR1、BCL2、TP53、STAT3、EQFR、TNF、MTCR等核心靶点,通过调控胰岛素抵抗信号通路、高级糖基化终末产物-受体信号通路、癌症中的蛋白聚糖信号通路、脂质和动脉粥样硬化信号通路等信号通路,发挥对糖尿病前期的治疗作用。结合“五原则”初步预测香草酸、芦丁、木犀草苷、药根碱、小檗碱等5种成分为小陷胸汤治疗糖尿病前期的潜在Q-marker,其含量依次为:1.25~19.10、0.50~4.31、0.21~3.59、1.17~18.39、25.95~312.99 µg·mL-1。结论 整合指纹图谱、化学计量学、网络药理学等多种分析手段,筛查小陷胸汤防治糖尿病前期的潜在Q-Marker,为小陷胸汤及其相关复方制剂的全面质量控制提供依据。
关键词:  小陷胸汤  质量标志物  糖尿病前期  指纹图谱  网络药理学  化学计量学
DOI:10.13506/j.cnki.jpr.2025.12.002
基金项目:国家自然科学基金项目(No.81202857);辽宁省自然科学基金项目(No.20170540617);辽宁中医药大学大学生创新创业训练计划项目(No.202310162003)
出版日期:2025-12-25
Analysis of quality markers of Xiaoxianxiong Decoction in the interventionof prediabetes based on fingerprint, chemometricsand network pharmacology
XIE Yan,DENG Shiren,CAO Yifan,LI Hanyue,ZOU Ye,XIA Linbo
(College of Pharmacy, Liaoning University of Traditional Medicine, Dalian 116600, China)
Abstract:
Objective To screen potential quality markers (Q-markers) of Xiaoxianxiong Decoction (XXXD) for treating prediabetes based on fingerprint, chemometrics and network pharmacology analysis. Methods Firstly, the differential markers of XXXD were analyzed by fingerprint and chemometrics. On this basis, the Q-Marker associated with XXXD in the treatment of prediabetes were screened out by using network pharmacology technology. Finally, a UHPLC method was established to determine the content of the predicted landmark components.Results The fingerprint of 15 batches was established and 24 common peaks were detected, from which 9 differential markers were selected by cluster analysis and OPLS-DA and confirmed by reference substance chromatography. Utilizing network pharmacology analysis, 5 core active ingredients, including vanillic acid, rutin, luteoloside, jatrorrhizine, berberine were screened out. They can act on seven core targets including ESR1, BCL2, TP53, STAT3, EQFR, TNF, MTCR and affect four core pathways including insulin resistance, AGE-RAGE, proteoglycans in cancer, lipid and atherosclerosis. It was preliminarily predicted that vanillic acid, rutin, luteoloside, jatrorrhizine, berberine were potential Q-Markers of XXXD for treating prediabetes, with the content of 1.25~19.10, 0.50~4.31, 0.21~3.59, 1.17~18.39, 25.95~312.99 µg·mL-1, respectively.Conclusion Combining the fingerprint, chemometrics, network pharmacology and content determination, this study predicted the Q-markers of XXXD. The results can provide reference for improving the comprehensive quality evaluation of XXXD.
Key words:  Xiaoxianxiong Decoction  Quality markers  Prediabetes  Fingerprint  Network pharmacology  Chemometrics
今日访问量:2469    总访问量:55338898
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司